IL7R and lobular neoplasia: Furthermore, a combination of sIL-7R and other biomarkers such as anti-C1q, anti-dsDNA, and/or complements C3 and C4 may increase the specificity for identification of active LN in SLE patients with complex disease manifestations [35].